Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LOSARTAN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1263 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Veal, N; Moal, F; Wang, JH; Vuillemin, E; Oberti, F; Roy, E; Kaassis, M; Trouve, R; Saumet, JL; Cales, P
      New method of cardiac output measurement using ultrasound velocity dilution in rats

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Heringlake, M; Bahlmann, L; Klaus, S; Wagner, K; Schmucker, P; Pagel, H
      Effects of angiotensin II and the AT(1) receptor antagonist losartan on the renal excretion of urodilatin

      KIDNEY & BLOOD PRESSURE RESEARCH
    3. Tepel, M; van der Giet, M; Zidek, W
      Efficacy and tolerability of angiotensin II type 1 receptor antagonists indialysis patients using AN69 dialysis membranes

      KIDNEY & BLOOD PRESSURE RESEARCH
    4. Neutel, JM
      The importance of 24-h blood pressure control

      BLOOD PRESSURE MONITORING
    5. Littlejohn, TW
      Clinical considerations in hypertensive black patients: the role of angiotensin II receptor blockers in combination with a diuretic

      BLOOD PRESSURE MONITORING
    6. McMurray, JJV
      Heart failure - Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

      HEART
    7. Gurlek, A; Kilickap, M; Dincer, I; Dandachi, R; Tutkak, H; Oral, D
      Effect ol losartan on circulating TNF alpha levels and left ventricular systolic performance in patients with heart failure

      JOURNAL OF CARDIOVASCULAR RISK
    8. Kempf, H; Corvol, P
      Angiotensin receptor(s) in fowl

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
    9. Song, JC; White, CM
      Olmesartan medoxomil (CS-866) - An angiotensin II receptor blocker for treatment of hypertension

      FORMULARY
    10. Song, JC; White, CM
      Focus on omapatrilat - A novel neutral endopeptidase/ACE inhibitor for treatment of hypertension and heart failure

      FORMULARY
    11. Keidar, S; Heinrich, R; Kaplan, M; Hayek, T; Aviram, M
      Angiotensin II administration to atherosclerotic mice increases macrophageuptake of oxidized LDL - A possible role for interleukin-6

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    12. Richer, C; Fornes, P; Domergue, V; De Gasparo, M; Giudicelli, JF
      Combined angiotensin II AT(1)-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats

      JOURNAL OF CARDIAC FAILURE
    13. Ghali, JK
      A clinician's perspective on clinical trials

      JOURNAL OF CARDIAC FAILURE
    14. Murali, B; Goyal, RK
      Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    15. Campbell, M; Sonkodi, S; Soucek, M; Wiecek, A
      A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    16. Sharkey, LC; Holycross, BJ; McCune, SA; Radin, MJ
      Obese female SHHF/Mcc-fa(cp) rats resist antihypertensive effects of renin-angiotensin system inhibition

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    17. Taylor, AA
      Is there a place for combining angiotensin-converting enzyme inhibitors and angiotensin-receptor antagonists in the treatment of hypertension, renal disease or congestive heart failure?

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    18. Struckman, DR; Rivey, MP
      Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure

      ANNALS OF PHARMACOTHERAPY
    19. Martineau, P; Goulet, J
      New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure

      ANNALS OF PHARMACOTHERAPY
    20. Murali, B; Goyal, RK
      Improvement in insulin sensitivity by losartan in non-insulin-dependent diabetic (NIDDM) rats

      PHARMACOLOGICAL RESEARCH
    21. Muders, F; Palkovits, M; Bahner, U; Kirst, I; Elsner, D; Jandeleit-Dahm, K
      Central inhibition of AT(1) receptors by eprosartan - In vitro autoradiography in the brain

      PHARMACOLOGICAL RESEARCH
    22. Park, CG; Leenen, FHH
      Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats

      JOURNAL OF KOREAN MEDICAL SCIENCE
    23. Vidt, DG; White, WB; Ridley, E; Rahman, M; Harris, S; Vendetti, J; Michelson, EL; Wang, R
      A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II

      JOURNAL OF HUMAN HYPERTENSION
    24. Fagard, R; Lijnen, P; Pardaens, K; Thijs, L; Vinck, W
      A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension

      JOURNAL OF HUMAN HYPERTENSION
    25. Garrett, PJ; Stewart, L; Leary, J; Lappin, TRJ
      Differential manipulation of the renin angiotensin system and epoietin requirements in maintenance haemodialysis patients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    26. Lopau, K; Hefner, L; Bender, G; Heidbreder, E; Wanner, C
      Haemodynamic effects of valsartan in acute renal ischaemia/reperfusion injury

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    27. Wilkinson-Berka, JL; Gibbs, NJ; Cooper, ME; Skinner, SL; Kelly, DJ
      Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    28. Buter, H; Navis, G; Dullaart, RPF; de Zeeuw, D; de Jong, PE
      Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    29. Lopez-Farre, A; de Miguel, LS; Monton, M; Jimenez, A; Lopez-Bloya, A; Gomez, J; Nunez, A; Rico, L; Casado, S
      Angiotensin II AT(1) receptor antagonists and platelet activation

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    30. Mora-Macia, J; Cases, A; Calero, F; Barcelo, P
      Effect of angiotensin II receptor blockade on renal disease progression inpatients with non-diabetic chronic renal failure

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    31. Lozano, JV; Llisterri, JL; Aznar, J; Redon, J
      Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    32. Esmatjes, E; Flores, L; Inigo, P; Lario, S; Ruilope, LM; Campistol, JM
      Effect of losartan on TGF-beta 1 and urinary albumin excretion in patientswith type 2 diabetes mellitus and microalbuminuria

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    33. Campistol, JM; Inigo, P; Larios, S; Bescos, M; Oppenheimer, F
      Role of transforming growth factor-beta(1) in the progression of chronic allograft nephropathy

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    34. Holgado, R; Anaya, F; Del Castillo, D
      Angiotensin II type 1 (AT(1)) receptor antagonists in the treatment of hypertension after renal transplantation

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    35. Lin, YZ; Tsuchihashi, T; Kagiyama, S; Matsumura, K; Abe, I
      The influence of chronic antihypertensive treatment on the central pressorresponse in SHR

      Hypertension research
    36. Nakata, T; Takeda, K; Harada, S; Oguni, A; Hatta, T; Kawa, T; Itoh, H; Sasaki, S; Nakagawa, M
      Role of the central nervous system in the development of hypertension produced by chronic nitric oxide blockade in rats

      Hypertension research
    37. Suzuki, J; Ohta, H; Hanada, K; Kawai, N; Ikeda, T; Nakao, M; Ikemoto, F; Nishikibe, M
      Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure

      Hypertension research
    38. Gavras, HP
      Issues in hypertension: Drug tolerability and special populations

      AMERICAN JOURNAL OF HYPERTENSION
    39. Stergiou, GS; Skeva, II; Baibas, NM; Kalkana, CB; Roussias, LG; Mountokalakis, TD
      Does the antihypertensive response to angiotensin converting enzyme inhibition predict the antihypertensive response to angiotensin receptor antagonism?

      AMERICAN JOURNAL OF HYPERTENSION
    40. Weir, MR; Weber, MA; Neutel, JM; Vendetti, J; Michelson, EL; Wang, RY
      Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: A clinical experience trial

      AMERICAN JOURNAL OF HYPERTENSION
    41. Meredith, P; Trenkwalder, P
      Angiotensin II antagonists for hypertension: There are differences in efficacy

      AMERICAN JOURNAL OF HYPERTENSION
    42. Dahlof, B
      Left ventricular hypertrophy and angiotensin II antagonists

      AMERICAN JOURNAL OF HYPERTENSION
    43. Lin, KS; Chan, SHH; Chan, JYH
      Tonic suppression of spontaneous baroreceptor reflex by endogenous angiotensins via AT(2) subtype receptors at nucleus reticularis ventrolateralis inthe rat

      SYNAPSE
    44. Maillard, JO; Descombes, E; Fellay, G; Regamey, C
      Repeated transient anuria following losartan administration in a patient with a solitary kidney

      RENAL FAILURE
    45. Broulik, PD; Tesar, V; Zima, T; Jirsa, M
      Impact of antihypertensive therapy on the skeleton: Effects of enalapril and AT(1) receptor antagonist losartan in female rats

      PHYSIOLOGICAL RESEARCH
    46. Smith, RD; Aurup, P
      A comparative review of the efficacy of antihypertensive agents on 24 h ambulatory blood pressure.

      CANADIAN JOURNAL OF CARDIOLOGY
    47. Unger, T
      Pharmacology of AT(1)-receptor blockers

      BLOOD PRESSURE
    48. Meredith, PA
      Clinical comparative trials of angiotensin II type 1 (AT(1))-receptor blockers

      BLOOD PRESSURE
    49. Trenkwalder, P
      AT(1)-receptor blocker-based combination therapy in hypertension

      BLOOD PRESSURE
    50. Hansson, L
      The relationship between dose and antihypertensive effect for different AT(1)-receptor blockers

      BLOOD PRESSURE
    51. Belz, GG
      Pharmacological differences among angiotensin II receptor antagonists

      BLOOD PRESSURE
    52. Mancia, G
      Clinical differences among angiotensin II receptor antagonists

      BLOOD PRESSURE
    53. Li, Q; Pfaffendorf, M; van Zwieten, PA
      Different types of antagonism by losartan and irbesartan on the effects ofangiotensin II and its degradation products in rabbit arteries

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    54. Mounier-Vehier, C; Devos, P
      Angiotensin II receptor antagonists: are they all the same?

      PRESSE MEDICALE
    55. Khan, BV; Navalkar, S; Khan, QA; Rahman, ST; Parthasarathy, S
      Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative coronary artery disease state in patients with coronary arterydisease

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    56. Wittstein, IS; Kass, DA; Pak, PH; Maughan, WL; Fetics, B; Hare, JM
      Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    57. Khaper, N; Singal, PK
      Modulation of oxidative stress by a selective inhibition of angiotensin IItype 1 receptors in MI rats

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    58. Cagigal, E; Gonzalez, L; Alonso, RM; Jimenez, RM
      pK(a) determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    59. Erk, N
      Analysis of binary mixtures of losartan potassium and hydrochlorothiazide by using high performance liquid chromatography, ratio derivative spectrophotometric and compensation technique

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    60. Acbay, O
      Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive Type 1 diabetic subjects

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    61. Petrov, VV; Fagard, RH; Lijnen, PJ
      Long-term treatment with enalapril or losartan does not show antiproliferative effects in peripheral blood mononuclear cells

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    62. Zacharieva, S; Atanassova, I; Natchev, E; Orbetzova, M; Tzingilev, D
      Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    63. Wei, HS; Lu, HM; Li, DG; Zhan, YT; Wang, ZR; Huang, X
      The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4

      CHINESE MEDICAL JOURNAL
    64. Amaral, SL; Papanek, PE; Greene, AS
      Angiotensin II and VEGF are involved in angiogenesis induced by short-termexercise training

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    65. Budzikowski, AS; Leenen, FHH
      ANG II in median preoptic nucleus and pressor responses to CSF sodium and high sodium intake in SHR

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    66. Zhang, J; Leenen, FHH
      AT(1) receptor blockers prevent sympathetic hyperactivity and hypertensionby chronic ouabain and hypertonic saline

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    67. Worck, RH; Staahltoft, D; Jonassen, TEN; Frandsen, E; Ibsen, H; Petersen, JS
      Brain angiotensin receptors and sympathoadrenal regulation during insulin-induced hypoglycemia

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    68. Kang, AK; Duncan, JA; Cattran, DC; Floras, JS; Lai, V; Scholey, JW; Miller, JA
      Effect of oral contraceptives on the renin angiotensin system and renal function

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    69. Scripture, CD; Pieper, JA
      Clinical pharmacokinetics of fluvastatin

      CLINICAL PHARMACOKINETICS
    70. Scordo, MG; Aklillu, E; Yasar, U; Dahl, ML; Spina, E; Ingelman-Sundberg, M
      Genetic polymorphism of cytochrome P4502C9 in a Caucasian and a black African population

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    71. Boscan, P; Allen, AM; Paton, JFR
      Baroreflex inhibition of cardiac sympathetic outflow is attenuated by angiotensin II in the nucleus of the solitary tract

      NEUROSCIENCE
    72. Conesa, AR; Fernandez, BM; Reques, FG
      Angioedema due to irbesartan

      REVISTA ESPANOLA DE CARDIOLOGIA
    73. Hu, K; Bahner, U; Gaudron, P; Palkovits, M; Ring, M; Fehle, A; Kruse, B; Ertl, G
      Chronic effects of ACE-inhibition (quinapril) and angiotensin-II type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei ofrats with experimental myocardial infarction

      BASIC RESEARCH IN CARDIOLOGY
    74. Masutomo, K; Makino, N; Fushiki, MSMS
      Effects of losartan on the collagen degradative enzymes in hypertrophic and congestive types of cardiomyopathic hamsters

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    75. Levine, B
      Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension

      CURRENT MEDICAL RESEARCH AND OPINION
    76. Thomas, GN; Critchley, JAJH; Tomlinson, B; Cockram, CS; Chan, JCN
      Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects

      CLINICAL ENDOCRINOLOGY
    77. Cheng, JWM; Kalis, MM; Feifer, S
      Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

      PHARMACOTHERAPY
    78. Laverman, GD; Henning, RH; de Jong, PE; Navis, G; de Zeeuw, D
      Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria

      AMERICAN JOURNAL OF KIDNEY DISEASES
    79. Russo, D; Minutolo, R; Pisani, A; Esposito, R; Signoriello, G; Andreucci, M; Balletta, MM
      Coadministration of losartan and enalapril exerts additive antiproteinuriceffect in IgA nephropathy

      AMERICAN JOURNAL OF KIDNEY DISEASES
    80. Katovich, MJ; Reaves, PY; Francis, SC; Pachori, AS; Wang, HW; Raizada, MK
      Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension

      JOURNAL OF HYPERTENSION
    81. Bosc, LVG; Kurnjek, ML; Muller, A; Terragno, NA; Basso, N
      Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging

      JOURNAL OF HYPERTENSION
    82. Fukuhara, M; Neves, LA; Li, P; Diz, DI; Ferrario, CM; Brosnihan, KB
      The angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in the rat hind-limb vascular bed in vivo

      JOURNAL OF HYPERTENSION
    83. Balt, JC; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA
      Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan

      JOURNAL OF HYPERTENSION
    84. Griffiths, CD; Morgan, TO; Delbridge, LMD
      Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake

      JOURNAL OF HYPERTENSION
    85. Wurzner, G; Gerster, JC; Chiolero, A; Maillard, M; Fallab-Stubi, CL; Brunner, HR; Burnier, M
      Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout

      JOURNAL OF HYPERTENSION
    86. Eliahou, H; Avinoach, I; Shahmurov, M; Ben-David, A; Shahar, C; Matas, Z; Zimlichman, R
      Renoprotective effect of angiotensin II receptor antagonists in experimental chronic renal failure

      AMERICAN JOURNAL OF NEPHROLOGY
    87. St-Louis, J; Sicotte, B; Bedard, S; Brochu, M
      Blockade of angiotensin receptor subtypes in arcuate uterine artery of pregnant and postpartum rats

      HYPERTENSION
    88. Henriksen, EJ; Jacob, S; Kinnick, TR; Teachey, MK; Krekler, M
      Selective angiotensin II receptor antagonism reduces insulin resistance inobese Zucker rats

      HYPERTENSION
    89. Bezerra, SMMS; dos Santos, CM; Moreira, ED; Krieger, EM; Michelini, LC
      Chronic AT(1) receptor blockade alters autonomic balance and sympathetic responses in hypertension

      HYPERTENSION
    90. Ferreira, AJ; Santos, RAS; Almeida, AP
      Angiotensin-(1-7): Cardioprotective effect in myocardial ischemia/reperfusion

      HYPERTENSION
    91. Dobrian, AD; Schriver, SD; Prewitt, RL
      Role of angiotensin II and free radicals in blood pressure regulation in arat model of renal hypertension

      HYPERTENSION
    92. McKinley, MJ; McBurnie, MI; Mathai, ML
      Neural mechanisms subserving central angiotensinergic influences on plasmarenin in sheep

      HYPERTENSION
    93. Bravo, R; Somoza, B; Ruiz-Gayo, M; Gonzalez, C; Ruilope, LM; Fernandez-Alfonso, MS
      Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats

      HYPERTENSION
    94. Cao, ZM; Cooper, ME; Jandeleit-Dahm, K; Gilbert, RE
      Blockade of the renin-angiotensin and endothelin systems on progressive renal injury - Response

      HYPERTENSION
    95. Leenen, FHH; Yuan, BX
      Prevention of hypertension by irbesartan in Dahl S rats relates to centralangiotensin II type 1 receptor blockade

      HYPERTENSION
    96. Ortiz, MC; Sanabria, E; Manriquez, MC; Romero, JC; Juncos, LA
      Role of endothelin and isoprostanes in slow pressor responses to angiotensin II

      HYPERTENSION
    97. Kanagy, NL; Walker, BR; Nelin, LD
      Role of endothelin in intermittent hypoxia-induced hypertension

      HYPERTENSION
    98. Kiarash, A; Pagano, PJ; Tayeh, M; Rhaleb, NE; Carretero, OA
      Upregulated expression of rat heart intercellular adhesion molecule-1 in angiotensin II- but not phenylephrine-induced hypertension

      HYPERTENSION
    99. Fuchs, SA; Koopmans, RP; Guchelaar, HJ; Brodie-Meijer, CCE; Meyboom, RHB
      Are angiotensin II receptor antagonists safe in patients with previous angiotensin-converting enzyme inhibitor-induced angioedema?

      HYPERTENSION
    100. Ikegami, H; Endoh, T; Suzuki, T
      Angiotensin II-induced inhibition of calcium currents in hamster submandibular ganglion neurons

      NEUROSCIENCE RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 17:34:29